A bill on the normally bipartisan issue of combating America’s opioid epidemic faced some opposition from Democrats in the House of Representatives on Wednesday, but still passed handily.
Dubbed the SUPPORT for Patients and Communities Reauthorization Act of 2025, the legislation reauthorizes funding for the fiscal years 2026 to 2030 for grants and other programs related to combating substance abuse. The bill passed the House on Wednesday by a bipartisan vote of 366-to-57.
“After several years of bipartisan collaboration on the SUPPORT Act, the House of Representatives passed legislation to continue fighting the fentanyl crisis by improving access to treatment, expanding recovery opportunities, and bolstering prevention initiatives,” Rep. Brett Guthrie, R-Ky., the sponsor of the bill, told The Daily Signal.
“The programs within the SUPPORT Act have made significant steps toward reducing the toll illicit fentanyl and fentanyl-related substances take on our communities. By reauthorizing this important legislation, we are increasing prevention initiatives, reducing drug-related deaths, and restoring hope for families. I thank my colleagues for their bipartisan commitment to saving lives,” the Kentucky congressman said.
Click this link for the original source of this article.
Author: Ray Hilbrich
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
